CD Bioparticles Launches Custom High-Loading EGCG Nanoparticles Development Service for Enhanced Combination Antitumor Therapy
Oct 23, 2026
CD Bioparticles launches High-Loading EGCG Nanoparticles Development services to support combination antitumor therapy and efficient drug delivery.
New York, NY, United States, October 23, 2026 /MarketersMEDIA/ -- CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its High-Loading EGCG Nanoparticles Development services to support researchers and biotechnology professionals in advancing combination antitumor therapy and efficient drug delivery. This drug-loading nanoparticle platform is based on Epigallocatechin-3-gallate (EGCG), and can help address key challenges associated with active ingredient loading, formulation stability, and delivery system optimization.
Natural products have great potential in biomedical research, drug development and clinical applications as they can be used medicinal sources to treat cancer, bacterial and fungal infections, inflammation and other diseases. These compounds in particular exhibit excellent biocompatibility, broad-spectrum biological activity and highly targeted effects, making them potent anti-cancer chemopreventive and chemotherapeutic agents with minimal side effects. Furthermore, these abundant and diverse natural sources can help to reduce the cost of cancer treatment.
EGCG is a natural phenolic compound found in foods and beverages (particularly tea) that exhibits a wide range of biological activities, including antioxidant, antibacterial, anti-obesity, anti-inflammatory and anticancer properties. The formation of EGCG self-assembled nanoparticles (ENPs) during the oxidation process is driven by intermolecular interactions, which maintain the stability of the nanoparticles. EGCG-based nanoparticles are an excellent carrier platform for antitumour drug delivery. To support researchers' work, CD Bioparticles now offers a high-loading EGCG-based nanoparticle platform designed specifically for combined antitumour therapy and efficient drug delivery.
CD Bioparticles offers custom, high-loading EGCG nanoparticle services to leverage advanced nanomedicine delivery technologies to achieve high loading, controlled release and targeted delivery, thereby maximizing the therapeutic potential of EGCG. The platform achieves loading rates of 30–50% (compared to 5–10% for traditional carriers), thereby increasing the effective dose while reducing the required carrier amount.
Additionally, the platform offers broad drug compatibility and is capable of simultaneously loading both hydrophilic and hydrophobic drugs, providing an efficient platform for multi-drug combination therapy. CD Bioparticles supports anti-tumour combination therapy regimens to achieve drug synergy and improve treatment outcomes. With a particle size range of 100–200 nm, CD Bioparticles' nanoparticles enhance tumour permeability and cellular uptake.
CD Bioparticles' comprehensive services include nanoparticle preparation customization, drug loading and capacity optimization, precise particle size and morphology characterization, stability and release performance evaluation, biocompatibility and efficacy assessment, and scalable production. These services can support researchers in various applications, such as in vitro drug screening and delivery mechanism studies, antitumour combination drug delivery, and targeted drug delivery and nanomedicine development.
Researchers and pharmaceutical developers working in oncology, targeted nanomedicine and sustained-release systems R&D who would like to learn more about CD Bioparticles' High-Loading-Capacity EGCG Nanoparticle Development services, or who would like to discuss custom project requirements and explore available development solutions, please visit https://www.cd-bioparticles.net/services/custom-high-loading-egcg-nanoparticles-development-service.html.
About CD Bioparticles
CD Bioparticles is an established drug delivery company that provides customized solutions for developing and manufacturing novel biocompatible drug delivery systems. It specializes in various formulation and drug delivery technologies, from conventional liposomes and PEGylated liposomes to polymer microspheres and nanoparticles for drug delivery. The company also provides contract research services for drug delivery formulation, formulation feasibility study, process development and scale-up, as well as analytical and non-clinical research services.
Contact Info:
Name: Richard J. Gray
Email: Send Email
Organization: CD Bioparticles
Website: https://www.cd-bioparticles.net/
Release ID: 89207091
In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.
More News
South Korea’s latest chart sensation has a secret: the singer isn’t human
A little-known South Korean music act has climbed the charts with a viral hit that has caught listeners off guard – not just for its sudden popularity, but because its vocals were generated entirely by artificial intelligence. Meomuru’s single, “Have You Become the Adult You Dreamed Of?”, climbed to No 2 on Melon’s Top 100 – South Korea’s flagship streaming chart – earlier this week. The track’s popularity has turned Meomuru into one of the country’s most-talked-about acts. The song was created...
Southeast Asia’s EV boom sidelines local car parts suppliers
Southeast Asia’s electric vehicle boom risks leaving the region’s smaller companies behind, as Chinese automotive giants bypass local part-makers in favour of imported components and locked-in supplier networks. Local manufacturers across Indonesia, Thailand and Malaysia are facing a double squeeze: demand is weakening for parts used in petrol and diesel cars, collectively known as internal combustion engine (ICE) vehicles, while steep barriers to entry also keep them out of EV supply...
FBI blames North Korea for stolen billions from Binance in biggest hack in history
The theft of billions of dollars from Binance within a matter of minutes, the biggest cryptocurrency heist in history, was orchestrated by North Korean hackers, the FBI said on Saturday. The Federal Bureau of Investigation said in a statement that this week’s attack was tied to “malicious cyber activity” by an entity known as TraderTraitor, the same actors behind a US$1.5 billion Bybit hack last year. The FBI asked cryptocurrency exchanges, blockchain analytics companies and others to block...
North Korean Hackers Stole Billions, the F.B.I. Says. It’s Not Their First Heist.
This week’s $6.3 billion hack of Binance is the largest to hit crypto, and would be the most that North Koreans have stolen in years of brazen cybercrime.
A Chinese Port Could Be a Lifeline for Spain, but Also a Threat
Residents say a proposed Chinese car plant in northern Spain will create new jobs. Others say it’s a long-term risk, distilling a debate about the costs and perks of ties to China.
SI is the future of AI – just not in the way Trump thinks
With US President Donald Trump recently pushing the use of “superintelligence” (SI) instead of artificial intelligence (AI) in national discourse, the acronym has gained unprecedented attention. It is the right acronym but the wrong meaning. In my opinion, SI should stand for “self-intelligence”. It probably explains why academics, critics and even major AI companies are calling for a temporary pause in AI development. They must have realised the technology’s current trajectory is headed down...
200 nations at Cop17 commit to biodiversity goals amid missed opportunities
Nearly 200 nations have struck hard-fought agreements at a UN biodiversity summit, but the outcome was accompanied by disappointment over missed opportunities to address humanity’s destructive toll on nature. Delegates cheered on Friday as crucial texts were approved in overtime but the celebrations were tempered by acrimonious debates and regret over limited progress on some of the most contentious issues. The Cop17 summit in Armenia sought to revive a landmark commitment to halt and reverse...
Apple Intelligence to roll out on iPhones in China in December with Alibaba backing
Apple’s long-awaited artificial intelligence features will be officially launched in China in December, ending two years of regulatory uncertainty as the US tech giant seeks to bring advanced technologies to its second-largest market with the help of Alibaba Group Holding. The first batch of Apple Intelligence services will roll out to Chinese iPhone users alongside the iOS 27.3 update in December, following an open beta test with developers starting November 4, the US company said in a...
Both Japan and China can help Bangladesh reach its full potential
In the Land of the Rising Sun, Bangladesh looks forward to a new dawn. The hope that comes with Prime Minister Tarique Rahman’s visit to Japan goes beyond the deals signed or the financial support expected. It shows a country that has emerged from authoritarian rule and wants to turn its new political voice into bigger economic chances and freedom of choice. For a government chosen by the people, foreign policy must answer one question: how does it make life better for the people who gave it...
Can battery swapping and energy storage power CATL’s next phase of growth?
Contemporary Amperex Technology Ltd (CATL) has doubled down on new businesses including battery swapping and energy storage as the world’s largest battery maker seeks new growth drivers amid intensifying price wars and mounting pressure on profitability. But the new path is far from straightforward. Established players like Nio have already built a strong presence in battery swapping, while BYD has reinforced its position in energy-storage systems. Lucas Zhang Liutong, director of Hong...
Liu Yandong, Rare Woman Among China’s Political Elite, Dies at 80
The former vice premier was one of just six women to have served on the Chinese Communist Party’s elite Politburo, though she was excluded from the top ranks of power.
China joins global race to reawaken brain-injury patients through ultrasound therapy
After spending three months in a coma following a brain haemorrhage, a patient in China has regained the ability to speak, eat and walk with support – part of an early clinical trial using targeted sound waves to help “wake up” severely damaged brains, according to state media. The technology, developed by a coalition including the Chinese Academy of Sciences’ Shenzhen Institutes of Advanced Technology, used focused ultrasound waves to stimulate regions deep within the brain without requiring...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.